ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRLD Prelude Therapeutics Inc

3.70
-0.17 (-4.39%)
Pre Market
Last Updated: 04:26:49
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -29.46M-30.41M-33.39M-29.12M-32.4M-33.39M-37.38M-34.34M
Pre Tax Income -27.37M-29.96M-28.64M-27.72M-30.43M-30.61M-33.08M-31.43M
Net Income -27.37M-29.96M-28.64M-27.72M-30.43M-30.61M-33.08M-31.43M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -27.37M-29.96M-28.64M-27.72M-30.43M-30.61M-33.08M-31.43M
EBITDA -29.14M-30.07M-33.02M-28.84M-32.12M-33.11M-37.05M-33.92M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000000
Operating Income -14.98M-28.11M-58.76M-113.74M-123.54M-132.28M
Pre Tax Income -14.68M-27.57M-56.93M-111.69M-115.44M-121.83M
Net Income -14.68M-27.57M-56.93M-111.69M-115.44M-121.83M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -5.332-7.539-0.651-1.173-1.205-1.11
EBIT -14.68M-27.57M-56.93M-111.69M-115.44M-121.83M
EBITDA -14.88M-27.73M-58.22M-112.82M-122.22M-131.11M